Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VKA versus NOACs in well-controlled non-valvular atrial fibrillation
NL-OMON41389Phase 4Active, not recruiting
- Sponsor
- University Medical Center Groningen
- Start
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dabigatran, rivaroxaban, sponsored by University Medical Center Groningen. Started Jan 2015; status: active, not recruiting.
02
Drugs
dabigatranrivaroxaban
Beyond the preview
Go deeper on NL-OMON41389.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON41389.